You could say the season has put on a new gear as we face a thick results calendar. The mood is already being set by how the market is digesting news from Indian Oil, Astral and Afcons. Then you have Bharat Petroleum and Bharat Electronics to contend with, which makes for an uncharacteristically high-stakes day of trading.
Earnings reactions already shaping trade
Hariprasad K, who heads Livelong Wealth, puts it plainly: “Stock-specific action is also expected to remain elevated due to key Q4 earnings announcements scheduled today.” And he has a point. On paper, more than 120 firms are coming out with numbers on Tuesday, 19 May, from all corners of the market – energy, pharma, defence, engineering and the like.
It follows a fairly even-keeled Monday, 18 May, when the Sensex put in a 77-point move to 75,315.04 and the Nifty 50 was up 6 points to 23,649.95. A solid enough footing before the deluge of data.
BEL is one to keep an eye on; its story on execution will likely colour the defence space. Motilal Oswal is calling for 14% year-on-year revenue growth, with an order book of Rs 730 billion to back it up. They do see margins tightening 320bp to 27.4% on a high base, but they’re still bullish on FY26.
For near-term trackers, Motilal Oswal flagged specific programme updates as key swing factors:
– QRSAM and Uttam radars progress
– Next-gen corvettes and Shatrughat EW
– Akash-NG and EoI for AMCA
The provisional figures have some weight to them. We’re talking INR300 billion in orders for BEL, $346 million of it from exports. Revenue, if you put aside other operating income, is up 16% to Rs 268 billion. Exports in particular are on a tear, up 34% to $142 million.
Why BPCL and BEL set the tone
Then there is BPCL. What they put on the table will matter. As K says, the way BPCL, BEL and Zydus Lifesciences talk about the future can be just as telling as the top-line numbers.
Pharma watch: Mankind and Zydus
Over at Mankind, Kotak sees the domestic side of the house growing 10% in 4QFY26, once you make allowances for the Mahananda divestment. Add in 5% from the international arm and you get 9% overall. They are also modelling a 110 bps drop in gross margin to 70.5%. With BSV in the mix, EBITDA should come in at Rs 7.6 billion, an 11% rise on last year.
Zydus is another one on the radar. The board is mulling over a share buyback with the Q4 report, so any word on how they plan to allocate capital could get the stock and its peers moving.
We are also seeing some after-hours activity from the likes of DOMS, Subros, GE Vernova and JK Paper. But with IGL, Astral and Afcons not quite meeting the mark, there is some caution in the air.
Don’t forget Indian Oil. When you have energy stocks that are so attuned to refining and marketing, what comes out of the commentary can have a ripple effect across the index.
For near-term trackers, Motilal Oswal flagged specific programme updates as key swing factors:
– QRSAM and Uttam radars progress
– Next-gen corvettes and Shatrughat EW
– Akash-NG and EoI for AMCA
Here are the near-term cues investors are watching:
– IOC’s Q4 print and commentary
– Order intake and execution visibility at BEL
– Oil marketing guidance from BPCL
Who is reporting today
The list for today is long. You have the big names like Mankind and Zee Entertainment, but also PI Industries, RITES, PNC Infratech, Dredging Corporation of India and others. It’s a full-spectrum affair.
In the end, it is about the read-throughs. Can the infra sector deliver? Are pharma margins holding? With the indices hovering near the top, the difference between what is earned and what is expected will be what makes or breaks the next phase.
